Navigation Links
Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh
Date:9/16/2008

Sir David Lane, chairman of Singapore A*STAR's Biomedical Research Council, has received the Royal Gold Medal for his outstanding contribution to cancer research through his discovery of p53 tumour suppressor gene.

The Royal Gold Medal is one of the highest accolades from the Royal Society of Edinburgh and is given to recipients whose intellectual endeavour have made an impact on people's lives worldwide.

Dr. Lane termed the tumour suppressor, p53, which was discovered back in 1979[1] as the "Guardian of the Genome". It is the single most crucial defence the cell has against cancer, and it affects cell cycle processes from cancer to ageing. p53 is a crucial target in cancer therapy and research into it is essential in understanding the cell cycle.

Co-discoverers of p53 are Arnold Levine and William Old as well as Dr. Lane.

Congratulating Dr. Lane, A*STAR (Agency for Science, Technology and Research) Chairman Lim Chuan Poh said, "David is most deserving of the award, and I extend my deepest congratulations to him. His outstanding work on p53 and the impact they have on cancer research worldwide highlight the contributions of basic research to advancing human healthcare. David is an example of how a passionate and persevering scientist can make such a difference to the world through research and development."

Dr. Lane is also the founder and chief executive of A*STAR's Experimental Therapeutics Centre, which carries out developmental work and pre-clinical evaluation on potential new drugs discovered in A*STAR research institutes. His work on p53 in Singapore is still ongoing at A*STAR's Institute of Molecular and Cell Biology.

He is concurrently the Chief Scientist for Cancer Research UK, UK's largest cancer charity.


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1

Related biology news :

1. American Society for Microbiology honors David J. Lipman
2. Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU
3. Prof. David Kisailus studies engineering and invention on the half-shell
4. David H. Ledbetter, PhD, FACMG is the 2008-2009 Luminex/ACMGF Award recipient
5. Inaugural Kavli laureates honored in Oslo ceremony
6. Leader of Human Genome Project honored with the Inamori Ethics Prize
7. Sen. Byron Dorgan to be honored
8. Springer editor honored with top environmental prize
9. Yales Anastas honored for leadership in founding of green chemistry
10. NJIT Provost Priscilla P. Nelson honored at National Academy of Engineering
11. Jeremy Jackson honored by Harvard Museum of Natural History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology: